Reversing the Irreversible: miRNA-Targeting Mesyl Phosphoramidate Oligonucleotides Restore Sensitivity to Cisplatin and Doxorubicin of KB-8-5 Epidermoid Carcinoma Cells › Research Explorer

Novosibirsk State University's Research Portal

Reversing the Irreversible: miRNA-Targeting Mesyl Phosphoramidate Oligonucleotides Restore Sensitivity to Cisplatin and Doxorubicin of KB-8-5 Epidermoid Carcinoma Cells

Research output: Contribution to journal › Article › peer-review

Российско-франко-японская лаборатория бионанотехнологии ФФ (РФЯЛБНТ)

Links

https://www.mdpi.com/2227-9059/13/12/3118

Svetlana Miroshnichenko
Rabia Demirel
Arseny Moralev
Olga Almieva
Andrey Markov
Ekaterina Burakova
Mikhail Maslov
Valentin Vlassov
Marina Zenkova

Original language	English
Article number	3118
Number of pages	26
Journal	Biomedicines
Volume	13
Issue number	12
Publication status	Published - 18 Dec 2025

Research areas

resistance to chemotherapy, antisense oligonucleotides, MDR, cancer, cisplatin, doxorubicin, ABCB1, microRNA, miR-17, miR-21, mesyl phosphoramidate

OECD FOS+WOS

3.02 CLINICAL MEDICINE
3.01 BASIC MEDICAL RESEARCH

ID: 73778852